Compare AbCellera Biologics Inc (ABCL) vs ClearPoint Neuro Inc (CLPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs ClearPoint Neuro Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: AbCellera Biologics Inc is far larger — about 6.6× ClearPoint Neuro Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | CLPT | |
|---|---|---|
Market Cap | $2.99B | $454.21M |
Sector | Health | Health |
52-Week High | $9.76 | $29.60 |
52-Week Low | $2.78 | $8.66 |
Enterprise Value | $2.58B | $488.79M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →
